{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T00:23:46Z","timestamp":1787185426441,"version":"build-2736575974"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T00:00:00Z","timestamp":1781049600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T00:00:00Z","timestamp":1787184000000},"content-version":"vor","delay-in-days":71,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100031022","name":"Center for Cancer Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100031022","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Breast cancer incidence is lower in women living in Asia than women living in North America and Northern Europe. However, large differences exist within Asia, for example, Mongolia\u2019s breast cancer rate is even lower than China\u2019s. Endogenous estrogens in Asian populations have been hypothesized to explain the disparity because of their strong positive correlations with breast cancer, though few studies have compared estrogen metabolites (EM) within Asia or between Asia and higher breast cancer risk countries.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      We measured urinary concentrations of estradiol and estrone (parent estrogens) and 13 EM (non-parent estrogens) formed by irreversible hydroxylation at the C-2, C-4, or C-16 positions of the steroid ring in premenopausal women living in Ulaanbaatar, Mongolia (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u2009282), Shanghai, China (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u2009121), and the United Kingdom (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u2009125). We performed analysis of variance (ANOVA) using a generalized linear model procedure to assess differences in hormone concentrations between British and Asian (Chinese and Mongolian), and Chinese and Mongolian. Exponentiated least square means were used to calculate percent differences. We compared differences in overall means adjusted for age, body mass index, and parity by country during the follicular, peri-ovulatory, and luteal phases.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Total, parent, and non-parent estrogen concentrations were generally higher in British than Asian women, while the non-parent to parent ratio was lower. While parent estrogens appeared higher in Chinese compared with Mongolian women, differences did not reach statistical significance except for peri-ovulatory estrone; total estrogen metabolites in the 2-, 4-, and 16-pathways were higher in Mongolian than Chinese women. The non-parent to parent ratio was highest in Mongolian women followed by Chinese women, with British women having the lowest ratio.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Total urinary estrogens, both parent and their metabolites, were higher in British compared with Asian women. Our data showing the ratio of non-parent to parent estrogens, possibility reflecting greater estrogen metabolism, in women living in Mongolia, with one of the lowest breast cancer rates globally, than in women living in China, and in Chinese compared with British women, are consistent with their relative breast cancer risks and suggestive of a potentially protective metabolic profile.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12885-026-16169-x","type":"journal-article","created":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T07:38:08Z","timestamp":1781077088000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Estrogen metabolites in premenopausal women living in China, Mongolia, and the United Kingdom"],"prefix":"10.1186","volume":"26","author":[{"given":"Lauren C.","family":"Houghton","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Davaasambuu","family":"Ganmaa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabel","family":"Dos Santos Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roni","family":"Falk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle L.","family":"Lui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathleene T","family":"Ulanday","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gretchen","family":"Gierach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xia","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dambadarjaa","family":"Davaalkham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca","family":"Troisi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,10]]},"reference":[{"issue":"3","key":"16169_CR1","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1097\/CM9.0000000000003921","volume":"139","author":"H Gu","year":"2026","unstructured":"Gu H, Wang R, Beeraka NM, et al. Global burden and trends of breast cancer: GLOBOCAN 2022 estimates of incidence and mortality in 185 countries. Chin Med J (Engl). 2026;139(3):404\u201314. https:\/\/doi.org\/10.1097\/CM9.0000000000003921.","journal-title":"Chin Med J (Engl)"},{"issue":"3","key":"16169_CR2","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/j.jncc.2025.02.002","volume":"5","author":"Y Zhang","year":"2025","unstructured":"Zhang Y, Ji Y, Liu S, et al. Global burden of female breast cancer: new estimates in 2022, temporal trend and future projections up to 2050 based on the latest release from GLOBOCAN. J Natl Cancer Cent. 2025;5(3):287\u201396. https:\/\/doi.org\/10.1016\/j.jncc.2025.02.002.","journal-title":"J Natl Cancer Cent"},{"key":"16169_CR3","doi-asserted-by":"publisher","unstructured":"Rong Z. Breast cancer burden among women of reproductive age in China, Japan, and, South, Korea. 1990\u20132021: a systematic analysis from the Global Burden of Disease Study 2021. Int J Clin Oncol. https:\/\/doi.org\/10.1007\/s10147-026-02989-1. Published online February 20, 2026.","DOI":"10.1007\/s10147-026-02989-1"},{"issue":"3","key":"16169_CR4","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1038\/bjc.2012.134","volume":"107","author":"RN Hoover","year":"2012","unstructured":"Hoover RN. That recognised risk factors can explain past and present international differences in breast cancer incidence: misconceptions 5. Br J Cancer. 2012;107(3):408\u201310. https:\/\/doi.org\/10.1038\/bjc.2012.134.","journal-title":"Br J Cancer"},{"key":"16169_CR5","doi-asserted-by":"publisher","unstructured":"Troisi R, Ganmaa D, Silva IDS, et al. The role of hormones in the differences in the incidence of breast cancer between Mongolia and the United Kingdom. PLoS ONE. 2014;9(12). https:\/\/doi.org\/10.1371\/journal.pone.0114455.","DOI":"10.1371\/journal.pone.0114455"},{"issue":"19","key":"16169_CR6","doi-asserted-by":"publisher","first-page":"1406","DOI":"10.1093\/jnci\/djj376","volume":"98","author":"AH Eliassen","year":"2006","unstructured":"Eliassen AH, Missmer SA, Tworoger SS, et al. Endogenous steroid hormone concentrations and risk of breast cancer among premenopausal women. J Natl Cancer Inst. 2006;98(19):1406\u201315. https:\/\/doi.org\/10.1093\/jnci\/djj376.","journal-title":"J Natl Cancer Inst"},{"issue":"3","key":"16169_CR7","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1158\/0008-5472.CAN-11-2507","volume":"72","author":"AH Eliassen","year":"2012","unstructured":"Eliassen AH, Spiegelman D, Xu X, et al. Urinary estrogens and estrogen metabolites and subsequent risk of breast cancer among premenopausal women. Cancer Res. 2012;72(3):696\u2013706. https:\/\/doi.org\/10.1158\/0008-5472.CAN-11-2507.","journal-title":"Cancer Res"},{"issue":"1","key":"16169_CR8","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1158\/1055-9965.EPI-20-0471","volume":"30","author":"LC Houghton","year":"2021","unstructured":"Houghton LC, Howland RE, Wei Y, et al. The steroid metabolome and breast cancer risk in women with a family history of breast cancer: The novel role of adrenal androgens and glucocorticoids. Cancer Epidemiol Biomarkers Prev. 2021;30(1):89\u201396. https:\/\/doi.org\/10.1158\/1055-9965.EPI-20-0471.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"10","key":"16169_CR9","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1016\/S1470-2045(13)70301-2","volume":"14","author":"TJ Key","year":"2013","unstructured":"Endogenous Hormones and Breast Cancer Collaborative Group, Key TJ, Appleby PN, et al. Sex hormones and risk of breast cancer in premenopausal women: a collaborative reanalysis of individual participant data from seven prospective studies. Lancet Oncol. 2013;14(10):1009\u201319. https:\/\/doi.org\/10.1016\/S1470-2045(13)70301-2.","journal-title":"Lancet Oncol"},{"issue":"10","key":"16169_CR10","doi-asserted-by":"publisher","first-page":"djw103","DOI":"10.1093\/jnci\/djw103","volume":"108","author":"SC Moore","year":"2016","unstructured":"Moore SC, Matthews CE, Ou Shu X, et al. Endogenous Estrogens, Estrogen Metabolites, and Breast Cancer Risk in Postmenopausal Chinese Women. J Natl Cancer Inst. 2016;108(10):djw103. https:\/\/doi.org\/10.1093\/jnci\/djw103.","journal-title":"J Natl Cancer Inst"},{"issue":"1","key":"16169_CR11","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1158\/1055-9965.221.14.1","volume":"14","author":"RT Falk","year":"2005","unstructured":"Falk RT, Fears TR, Xu X, et al. Urinary estrogen metabolites and their ratio among Asian American women. Cancer Epidemiol Biomarkers Prev. 2005;14(1):221\u20136.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"3","key":"16169_CR12","first-page":"161","volume":"5","author":"A Shreves","year":"2020","unstructured":"Shreves A, Davaasambuu G, Raj P, Troisi R. Mongolian Breast Cancer Incidence: A Follow-up Report. Asian Pac J Cancer Care. 2020;5(3):161\u20135.","journal-title":"Asian Pac J Cancer Care"},{"issue":"1","key":"16169_CR13","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1186\/s40880-017-0234-3","volume":"36","author":"R Zheng","year":"2017","unstructured":"Zheng R, Zeng H, Zhang S, Chen W. Estimates of cancer incidence and mortality in China, 2013. Chin J Cancer. 2017;36(1):66. https:\/\/doi.org\/10.1186\/s40880-017-0234-3.","journal-title":"Chin J Cancer"},{"issue":"11","key":"16169_CR14","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1093\/aje\/kwi322","volume":"162","author":"W Zheng","year":"2005","unstructured":"Zheng W, Chow WH, Yang G, et al. The Shanghai Women\u2019s Health Study: rationale, study design, and baseline characteristics. Am J Epidemiol. 2005;162(11):1123\u201331. https:\/\/doi.org\/10.1093\/aje\/kwi322.","journal-title":"Am J Epidemiol"},{"issue":"5","key":"16169_CR15","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1093\/jnci\/djq563","volume":"103","author":"O Fletcher","year":"2011","unstructured":"Fletcher O, Johnson N, Orr N, et al. Novel breast cancer susceptibility locus at 9q31.2: results of a genome-wide association study. J Natl Cancer Inst. 2011;103(5):425\u201335. https:\/\/doi.org\/10.1093\/jnci\/djq563.","journal-title":"J Natl Cancer Inst"},{"issue":"9","key":"16169_CR16","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1093\/jnci\/djs156","volume":"104","author":"N Johnson","year":"2012","unstructured":"Johnson N, Walker K, Gibson LJ, et al. CYP3A variation, premenopausal estrone levels, and breast cancer risk. J Natl Cancer Inst. 2012;104(9):657\u201369. https:\/\/doi.org\/10.1093\/jnci\/djs156.","journal-title":"J Natl Cancer Inst"},{"issue":"20","key":"16169_CR17","doi-asserted-by":"publisher","first-page":"6646","DOI":"10.1021\/ac050697c","volume":"77","author":"X Xu","year":"2005","unstructured":"Xu X, Veenstra TD, Fox SD, et al. Measuring fifteen endogenous estrogens simultaneously in human urine by high-performance liquid chromatography-mass spectrometry. Anal Chem. 2005;77(20):6646\u201354. https:\/\/doi.org\/10.1021\/ac050697c.","journal-title":"Anal Chem"},{"issue":"12","key":"16169_CR18","doi-asserted-by":"publisher","first-page":"3411","DOI":"10.1158\/1055-9965.EPI-08-0355","volume":"17","author":"RT Falk","year":"2008","unstructured":"Falk RT, Xu X, Keefer L, Veenstra TD, Ziegler RG. A Liquid Chromatography-Mass Spectrometry Method for the Simultaneous Measurement of 15 Urinary Estrogens and Estrogen Metabolites: Assay Reproducibility and Interindividual Variability. Cancer Epidemiol Biomarkers Prev. 2008;17(12):3411\u20138. https:\/\/doi.org\/10.1158\/1055-9965.EPI-08-0355.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"8","key":"16169_CR19","doi-asserted-by":"publisher","first-page":"1947","DOI":"10.1002\/ijc.28528","volume":"134","author":"R Kaaks","year":"2014","unstructured":"Kaaks R, Tikk K, Sookthai D, et al. Premenopausal serum sex hormone levels in relation to breast cancer risk, overall and by hormone receptor status - results from the EPIC cohort. Int J Cancer. 2014;134(8):1947\u201357. https:\/\/doi.org\/10.1002\/ijc.28528.","journal-title":"Int J Cancer"},{"issue":"1","key":"16169_CR20","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1007\/s10552-018-1105-1","volume":"30","author":"SB Coburn","year":"2019","unstructured":"Coburn SB, Stanczyk FZ, Falk RT, et al. Comparability of serum, plasma, and urinary estrogen and estrogen metabolite measurements by sex and menopausal status. Cancer Causes Control. 2019;30(1):75\u201386. https:\/\/doi.org\/10.1007\/s10552-018-1105-1.","journal-title":"Cancer Causes Control"},{"issue":"4","key":"16169_CR21","doi-asserted-by":"publisher","first-page":"185","DOI":"10.5301\/JBM.2010.6086","volume":"25","author":"BJ Fuhrman","year":"2010","unstructured":"Fuhrman BJ, Xu X, Falk RT, et al. Stability of 15 estrogens and estrogen metabolites in urine samples under processing and storage conditions typically used in epidemiologic studies. Int J Biol Markers. 2010;25(4):185\u201394.","journal-title":"Int J Biol Markers"},{"issue":"3","key":"16169_CR22","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1080\/02841860701592400","volume":"47","author":"K Holl","year":"2008","unstructured":"Holl K, Lundin E, Kaasila M, Grankvist K, Afanasyeva Y, Hallmans G, Lehtinen M, Pukkala E, Surcel HM, Toniolo P, Zeleniuch-Jacquotte A, Koskela P, Lukanova A Effect of long-term storage on hormone measurements in samples from pregnant women: the experience of the Finnish Maternity Cohort. Acta Oncol. 2008;47(3):406\u201312. https:\/\/doi.org\/10.1080\/02841860701592400.","journal-title":"Acta Oncol"},{"issue":"7","key":"16169_CR23","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1038\/bjc.1997.183","volume":"75","author":"HV Thomas","year":"1997","unstructured":"Thomas HV, Key TJ, Allen DS, Moore JW, Dowsett M, Fentiman IS, Wang DY A prospective study of endogenous serum hormone concentrations and breast cancer risk in premenopausal women on the island of Guernsey. Br J Cancer. 1997;75(7):1075\u20139. . https:\/\/doi.org\/10.1038\/bjc.1997.183.","journal-title":"Br J Cancer"},{"issue":"2","key":"16169_CR24","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.psyneuen.2006.11.008","volume":"32","author":"LR Stroud","year":"2007","unstructured":"Stroud LR, Solomon C, Shenassa E, Papandonatos G, Niaura R, Lipsitt LP, Lewinn K, Buka SL Long-term stability of maternal prenatal steroid hormones from the National Collaborative Perinatal Project: still valid after all these years. Psychoneuroendocrinology. 2007;32(2):140\u201350. . https:\/\/doi.org\/10.1016\/j.psyneuen.2006.11.008.","journal-title":"Psychoneuroendocrinology"},{"issue":"11","key":"16169_CR25","doi-asserted-by":"publisher","first-page":"2860","DOI":"10.1158\/1055-9965.EPI-09-0591","volume":"18","author":"AH Eliassen","year":"2009","unstructured":"Eliassen AH, Ziegler RG, Rosner B, et al Reproducibility of fifteen urinary estrogens and estrogen metabolites over a 2- to 3-year period in premenopausal women. Cancer Epidemiol Biomarkers Prev. 2009;18(11):2860\u20138. https:\/\/doi.org\/10.1158\/1055-9965.EPI-09-0591.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"1","key":"16169_CR26","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1177\/1933719113492211","volume":"21","author":"HH Li","year":"2014","unstructured":"Li HH, Zhao YJ, Li Y, et al Estradiol 17\u03b2 and its metabolites stimulate cell proliferation and antagonize ascorbic acid-suppressed cell proliferation in human ovarian cancer cells. Reprod Sci. 2014;21(1):102\u201311. https:\/\/doi.org\/10.1177\/1933719113492211.","journal-title":"Reprod Sci"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12885-026-16169-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-026-16169-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-026-16169-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T23:25:20Z","timestamp":1787181920000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12885-026-16169-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,10]]},"references-count":26,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["16169"],"URL":"https:\/\/doi.org\/10.1186\/s12885-026-16169-x","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,10]]},"assertion":[{"value":"26 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The ethical review boards at Mongolia\u2019s Ministry of Health, the National University of Mongolia, the United States (U.S.) National Cancer Institute (National Institutes of Health), the Harvard School of Public Health, Vanderbilt University, and the London School of Hygiene and Tropical Medicine approved this study. All participants provided written, informed consent.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"1000"}}